Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/2/2026 | Sector Weight | KeyBanc Capital Markets | |
| 8/15/2024 | Buy → Neutral | Sidoti | |
| 10/9/2023 | $39.00 | Buy | B. Riley Securities |
| 6/15/2023 | $3.40 | Overweight | Cantor Fitzgerald |
| 5/11/2022 | $27.00 | Buy | Lake Street |
4 - Kimball Electronics, Inc. (0001606757) (Issuer)
4 - Kimball Electronics, Inc. (0001606757) (Issuer)
4 - Kimball Electronics, Inc. (0001606757) (Issuer)
8-K - Kimball Electronics, Inc. (0001606757) (Filer)
11-K - Kimball Electronics, Inc. (0001606757) (Filer)
SD - Kimball Electronics, Inc. (0001606757) (Filer)
KeyBanc Capital Markets initiated coverage of Kimball Electronics with a rating of Sector Weight
Sidoti downgraded Kimball Electronics from Buy to Neutral
B. Riley Securities initiated coverage of Kimball Electronics with a rating of Buy and set a new price target of $39.00
Kimball Electronics, Inc. (NASDAQ:KE) today announced a significant milestone in its evolution, with the successful completion of the first phase of its rebranding to Kimball Solutions at its Jasper and Indianapolis, Indiana facilities, effective July 1, 2026. This milestone reflects the Company’s continued transformation from a traditional electronics manufacturing services (EMS) provider into a global, diversified manufacturing and engineering solutions partner. A Name That Reflects a Broader Vision The transition to Kimball Solutions underscores the Company’s expanded capabilities across the full product lifecycle from design engineering and supply chain management to advanced manu
Helvoet is an advanced medical CDMO specializing in highly automated micro-molding and precision injection molding for microfluidics, diagnostics, and drug delivery applications Acquisition establishes a global medical CMO platform by expanding the Kimball manufacturing footprint in Europe while adding production facilities in India Transaction is expected to be accretive to fiscal 2027 adjusted earnings, increasing sales in the Kimball medical vertical in the low double-digit range Helvoet customer base includes blue-chip medical companies complementary to the Kimball portfolio, creating opportunities for expanded program wins and possible vertical integration Kimball manu
Kimball Electronics, Inc. (NASDAQ:KE) today announced the Company will be attending the 26th Annual B. Riley Securities Institutional Investor Conference, which is being held May 20-21 at the Ritz Carlton Marina Del Rey, CA. Jana Croom, Chief Financial Officer, and Andrew Regrut, Vice President, Investor Relations, Strategic Development, and Treasurer, will be available for one-on-one meetings throughout the conference. For additional information about the conference or to schedule a one-on-one meeting with Kimball Electronics management, please contact your B. Riley Securities representative or the Company's investor relations team at Investor.Relations@kimballelectronics.com or KE@gatew
Kimball Electronics, Inc. (NASDAQ:KE) today announced the Company is intensifying its focus on strategic development with the appointment of a new member to its leadership team. Andrew D. Regrut, Treasurer and Investor Relations Officer, will now also lead the strategic development efforts of the Company. Commenting on Mr. Regrut's expanded role, Jana T. Croom, Chief Financial Officer, stated, "I'm thrilled to be announcing Andy's promotion and addition to our leadership team. He has been instrumental in our recent efforts to optimize debt levels through improved working capital management and global cash movement. We look for his energy and intensity to elevate our focus on strategic d
Strategic healthcare leader brings more than 30 years of global experience to PureTech's Board following notable positions with Cardinal Health, Teva Pharmaceuticals and McKinsey & Company PureTech Health plc (NASDAQ:PRTC, LSE: PRTC))) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announced that Michele Holcomb, PhD, will join its board of directors as an independent non-executive director. Dr. Holcomb's appointment will take effect as of September 23, 2024. She brings more than 30 years of expertise leading global healthcare companies through strategic inflection points and preparing in
600 new employees will be based in Asia and the U.S., with offices in Vietnam, China, India, Japan and Silicon Valley. MONTREAL, Aug. 1, 2024 /PRNewswire/ - Averna, a leading global test & quality solutions provider, announced the acquisition of Global Equipment Services, Inc. (GES), a division of Kimball Electronics, Inc. (NASDAQ:KE) specialized in automation, test and measurement solutions for industries such as consumer electronics, semiconductor and medical devices. This strategic acquisition combines both companies' strengths and footprint to create one of the largest in
Helvoet is an advanced medical CDMO specializing in highly automated micro-molding and precision injection molding for microfluidics, diagnostics, and drug delivery applications Acquisition establishes a global medical CMO platform by expanding the Kimball manufacturing footprint in Europe while adding production facilities in India Transaction is expected to be accretive to fiscal 2027 adjusted earnings, increasing sales in the Kimball medical vertical in the low double-digit range Helvoet customer base includes blue-chip medical companies complementary to the Kimball portfolio, creating opportunities for expanded program wins and possible vertical integration Kimball manu
Third Quarter 2026 Highlights Revenue of $352.9 million, a sequential increase of 3.4% compared to Q2 Sales in the medical vertical increased 10.2% versus the prior quarter Operating income of $11.8 million, or 3.3% of net sales, adjusted operating margin of 4.2% Cash from operations of $14.9 million, the ninth consecutive quarter of positive operating cash generation Debt of $163.0 million and borrowing capacity of $276.0 million Cash Conversion Days of 90, an improvement compared to both the prior quarter and Q3 of fiscal 2025 Invested $4.0 million to repurchase 165,000 shares of common stock Company affirms guidance for fiscal 2026 with adjusted operating margin e
Kimball Electronics, Inc. (NASDAQ:KE) today announced that it will report third quarter fiscal year 2026 financial results on Tuesday, May 5, 2026, after the closing of the market. The company will host a conference call and live webcast to review the results on Wednesday, May 6, 2026, at 10:00 a.m. Eastern Time. The telephone number to access the conference call is 877-407-8293 / +1 201-689-8349. A live webcast of the conference call can be accessed at investors.kimballelectronics.com. For those unable to participate in the live webcast, a replay will be archived at investors.kimballelectronics.com. About Kimball Electronics, Inc. Kimball Electronics is a global, multifaceted ma
SC 13G/A - Kimball Electronics, Inc. (0001606757) (Subject)
SC 13G/A - Kimball Electronics, Inc. (0001606757) (Subject)
SC 13G/A - Kimball Electronics, Inc. (0001606757) (Subject)